"
BIOTEC Dresden/Notepad/19 July 2010
From 2010.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Biotec_Dresden/Header}} | {{Biotec_Dresden/Header}} | ||
| + | <html> | ||
| + | <head> | ||
| + | <style type="text/css"> | ||
| + | #bodyContent p, #bodyContent pre, #bodyContent table { | ||
| + | margin:10px 30px; | ||
| + | } | ||
| + | </style> | ||
| + | </head> | ||
| + | </html> | ||
[Transformation | http://partsregistry.org/Help:Transformation_Protocol] of the plasmids pETMM43 and pETMM-11-ZZ from the protein purification facility in DH5α. | [Transformation | http://partsregistry.org/Help:Transformation_Protocol] of the plasmids pETMM43 and pETMM-11-ZZ from the protein purification facility in DH5α. | ||
Revision as of 19:37, 14 August 2010
[Transformation | http://partsregistry.org/Help:Transformation_Protocol] of the plasmids pETMM43 and pETMM-11-ZZ from the protein purification facility in DH5α. Both with kanamycin resistance.
July |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 |
August |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | |
October |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 |
